-
On the Path to End Tuberculosis: How Social Franchising Can Effectively Engage Private Practitioners
Over the past 20 years, that rallying cry has gone from fantasy to imperative. Since the advent of the World Health Organization’s directly observed treatment strategy in 1995, more than 61 million people have been successfully treated for tuberculosis, and new TB cases and TB-related deaths are on the decline. Furthermore, countries have achieved the Millennium Development Goal of halting and reversing the TB epidemic by 2015. Thus, today, we have important successes to celebrate. Ending TB is within reach.
- Categories
- Health Care
-
Indian Doctors Find Success in Tackling the ‘Invisible Burden’ of Tuberculosis
When Indian street-food seller Kumar Pal first began treatment for multi-drug resistant tuberculosis two years ago, he quickly spiraled into depression and gave up hope of living.
- Categories
- Health Care
- Region
- South Asia
-
Viewpoint: Be Bold: How Gavi Will Immunise Another 300 Million Children
A challenge stands before us: ensuring immunisation of the world’s poorest children. If we, as global citizens can meet it, we will help protect the lives of millions in places too poor to afford vaccines.
- Categories
- Health Care
- Tags
- vaccines
-
South Africa Taps Emocha for Tuberculosis-Fighting Mobile Apps
Johns Hopkins-affiliated health IT startup emocha is marking World TB Day with the launch of a new system in South Africa.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
New Drugs Still Out of Reach for Most in India, World Tuberculosis Hotspot
The case of a Mumbai tailor cured of an extremely resistant form of tuberculosis this week has revived debate over a new drug to which the Indian government has limited access, prompting calls for change.
- Categories
- Health Care
- Region
- South Asia
-
Michael Bloomberg Backs Project to Collect Foreign Health Data
Former New York City Mayor Michael Bloomberg is backing a new project that will collect basic health data for countries in Africa, southeast Asia, and Latin America.
- Categories
- Health Care
-
Pharmaceutical Incentives Cost Lives, Yale Professor Says
A Yale paper published online on Feb. 11 in the Journal of Global Health argues that implementation of a new agency to fund pharmaceutical companies could have decreased the severity of the recent Ebola outbreak.
- Categories
- Health Care
-
The Future of Chronic Diseases Through the Eyes of Youth
Young people make up nearly half of the world’s population. And even though global health policy-making impacts them — think vaccinations, reproductive health or preventative care — young people far too often don’t have a say in that process.
- Categories
- Health Care
